Business
Sonoma Pharmaceuticals and MicroSafe Group Announce That Microsafe® Disinfectant & Sanitizer Manufactured Using Sonoma’s Microcyn® Technology Successfully Passed Material Compatibility Testing for Both Airbus and Boeing Commercial Transport Aircraft
WOODSTOCK, Ga.--(BUSINESS WIRE)-- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous
About this update from Sonoma Pharmaceuticals, Inc.
[{"type":"text","content":" WOODSTOCK, Ga.--(BUSINESS WIRE)--\nSonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care and dermatological conditions and the MicroSafe Group Dubai announce that Microsafe® Disinfectant & Sanitizer manufactured by Sonoma successfully passed both the Boeing Specification Standard BSS7434 and the British Aerospace Airbus specification AIMS09-00-002. The passing of these tests validate the compatibility and safety of the Microsafe® Disinfectant & Sanitizer on the interior and exterior parts and materials of Boeing and Airbus commercial transport aircraft.\n\n\n“Conforming with the material compatibility standards set forth by Boeing & Airbus, together with our 30 second kill time of bacteria & viruses on hard surfaces, allows us to advance the use of Microsafe® Disinfectant & Sanitizer into the airline industry. Recently, Microsafe® Disinfectant & Sanitizer (brand name “Nanocyn” in Australia) was approved and entered into the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV-2 (COVID-19) with a 30 second kill time,” said Mrs. Safa Qadumi, Founder and CEO of the MicroSafe Group Dubai.\n\n\n“It’s important to note, that the Microsafe® Disinfectant & Sanitizer has been successfully used for nearly 20 years globally to fight the spread of infectious disease and during this time, we have earned numerous global regulatory approvals and amassed reputable scientific evidence not only as a surface disinfectant, but as a skin and wound antiseptic as well,” Mrs. Safa, continued.\n\n\n“We are excited that these tests show that use of our Microcyn® technology conforms to aircraft manufacturer standards. These test results expand our potential sales channels into the airline industry,” said Amy Trombly, CEO of Sonoma Pharmaceuticals. She continued, “As disinfectant and sanitizer use has increased due to the pandemic that has spread around the world, we are excited to work with our partners, like MicroSafe Group, to make a positive difference by providing safer environments for people during this difficult time. As an international company selling products in 53 countries around the world, we are continuously seeking additional partners to expand our domestic and global r...